Quarterlytics / Technology / ProPhotonix

ProPhotonix

ppix · LSE Technology
Claim this profile
Ticker ppix
Exchange LSE
Sector Technology
Industry
Employees 51-200
← All annual reports
FY2014 Annual Report · ProPhotonix
Sign in to download
Loading PDF…
Annual Report
2014

About the pictures on the front cover (left to right): 

Modular LED line Light, Multi-Wavelength, Highly Uniform, Long Working Distance 

The  modular  LED  line  light  produces  a  highly  uniform  line  utilizing  dual-axis  collimation.  The  light  can  be 
configured  to  maintain  a  specific  line  thickness  across  a  wide  working  distance  range.  Highly  uniform  line 
lights  have  applications  within  the  machine  vision  industry  for  various  types  of  inspection  such  as  rail, 
container, and optical sorting applications.  

UV COBRA™ Cure Line Light 

UV COBRA™ Cure is a compact LED line light illuminator with a modular form factor. It produces a uniform 
line and offers field adjustable optics to allow users to select the optimum lens position for their application in 
the field. The light has applications in machine vision systems, adhesive  curing  assembly lines  and industrial 
scale printing applications. 

Green 3D PRO Laser Modules 

The 3D PRO™ Laser Green series includes the 3D PRO Green, the Adjustable Focus 3D PRO Laser Green and 
the 3D PRO Laser Mini Green. These direct emission green structured light lasers deliver excellent uniformity 
making them an ideal solution for a wide range of applications such as 3D Printing and 3D imaging. 

Compact LED Light Sources for Endoscopic applications 

ProPhotonix has developed LED light sources for endoscopic applications in several different form factors.  The 
pictured  light  engine  placement  at  the  tip  of  the  endoscope  is  unique.  ProPhotonix  utilized  innovative 
technologies to overcome thermal issues while staying within size and performance constraints of the product. 
A 3D ceramic substrate containing laser patterning of interconnects forms the platform on which the LEDs are 
precisely placed and bonded allowing for a precise placement into the scope.  

Solutions for LEDs 
ProPhotonix Limited (IRE) 
3020 Euro Business Park 
Little Island 
Cork, Ireland 
+353-21-5001300 

Solutions for Lasers 
ProPhotonix Limited 
Sparrow Lane, 
Hatfield Broad Oak 
Hertfordshire, CM22 7BA UK 
+44-1279-717170 

Corporate 
ProPhotonix Limited 
32 Hampshire Road 
Salem, NH 03079 
+1-603-893-8778 

Page 2 

 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Business Activities: 

ProPhotonix consists of two business units: an LED systems manufacturing business based in  Ireland (Cork), 
and a laser modules production and laser diode distribution business located in the United Kingdom (Hatfield 
Broad  Oak).    Corporate  headquarters  and  the  North  American  sales  activities  are  based  in  Salem,  New 
Hampshire,  USA.    The  fundamental  strategy  of  the  Company  is  growth  in  revenue  through  its  existing 
customers, new customer activity, and new product and market expansion.   

ProPhotonix  Limited  sells  its  products  principally  into  three  markets:  industrial,  (primarily  machine  vision 
illumination), medical, and homeland security and defense.  The Company foresees growth opportunities in all 
three markets it serves which are briefly described below:  

Industrial (Machine Vision) 

Within the industrial market, machine vision is the term used to describe computerized analysis for controlling 
manufacturing processes, for example automated inspection.  In terms of quality and speed, lighting is often a 
critical  component  in  machine  vision  and  the  Company  manufactures  both  LED  systems  and  lasers  designed 
specifically for this market.  The recently enhanced 3D Pro Laser line generators and improved LED line light 
family specifically address this market. 

Medical 

The Company has experienced successes in the medical (including dental) market and has gained a foothold in 
the market, supplying a variety of applications, with current customers including the world leader in stationary 
imaging equipment, a portable x-ray equipment manufacturer, a dental imaging manufacturer and also a pioneer 
in the manufacturing of devices offering eye tracking capability utilizing ProPhotonix’s custom infrared LED 
arrays.    The  Company  intends  to  broaden  its  product  marketing  effort  in  the  medical  field  since  it  offers 
significant long-term revenue growth opportunities. 

Homeland Security & Defense 

LED systems, laser modules and laser diodes are used in a wide variety of applications in the security and 
defense fields.    The Company currently supplies several defense sighting manufacturers in the US and Europe, 
as well as leading manufacturers of Auto Number Plate Recognition systems.  This market offers significant 
growth opportunities for ProPhotonix over the next several years and the Company is currently marketing its 
laser and LED capabilities to additional security and Optical Character Recognition systems companies in this 
market space. 

Page 3 

 
 
 
 
 
 
 
 
 
To the Shareholders of ProPhotonix Limited: 

2014 Annual Report to Shareholders 

2014 has been a landmark year in a number of respects – our first full year of positive operating income in 
nearly  two  decades,  our  first  full  year  of  positive  EBITDA  in  fourteen  years,  and  we  have  achieved  three 
consecutive  half-yearly  periods  of  positive  EBITDA.    In  addition  to a  continuation  of  improving  financial 
results,  Team  ProPhotonix  has  been  diligently  pursuing  new  customer  engagement  and  new  product  and 
market initiatives which help set the stage for 2015 and beyond. 

Financial Progress: 
Our  financial  performance  has  dramatically  improved  during  2014.    Revenue  grew  a  modest  5%  while 
operating income improved by $1.3 million ($0.7 million adjusted for 2013 one-time charges) and EBITDA 
improved  similarly  by  $1.3  million  ($0.7  million  adjusted for  the  2013  one-time  charges  of  $0.6  million).  
The  growth  in  revenue,  improvement  in  the  gross  margin  rate,  and  continuing  costs reductions,  all factors 
into the continued financial improvement of ProPhotonix.  I am pleased with the revenue growth in 2014, but 
more importantly, the improvement in operating income and EBITDA.  The balance sheet also continued to 
improve in 2014.  Term debt was reduced by $293,000 in accordance with the various loan facilities and total 
available credit from the Company’s various loan facilities was $1.9 million as of December 31, 2014.   

During 2014, order bookings declined 9% to $16.1 million from 2013 and the book-to-bill ratio ended at 0.98 
(2013:  1.13).  Our order backlog at December 31, 2014 was down 20% from 2013 to $5.6 million. Several 
factors contributed to the decline in bookings and backlog including:  customers’ reluctance to place large 
blanket orders opting instead for smaller short-cycle orders, business softness or delays in several industrial 
customers,  the  decline  in  foreign  currency  translation  rates  from  year-end  2013  to  year-end  2014  and,  as 
compared to 2013, several large non-recurring engineering (NRE) orders received in 2013 and completed in 
2014.   

Since  May  2014,  the  exchange  rates  of  the  Euro  and  British  Pound  (GBP) to  the  dollar  (USD)  have  been 
weakening.  The Euro to USD and GBP to USD exchange rates, as of March 18, 2015, have eroded 20% and 
10% respectively from the 2014 average and 13% and 5% respectively since the beginning of the year.  The 
effect  of a  strengthening  dollar  may  negatively  impact  2015  revenue  growth on  a  comparative  basis  when 
Euro and GBP denominated revenue is translated into USD.  EBITDA will likely be less impacted due to the 
translation of costs at lower exchange rates, our natural operating hedges in the locations we operate in and 
the supply chain we utilize.  Recent booking trends, the macroeconomic environment, and foreign exchange 
rate impacts cause us to be cautious for the first half of 2015, but we remain very positive about our growing 
business  pipeline  and  confident  in  our  ability  to  achieve  continued  positive  momentum  toward  our 
profitability objectives. 

Customer development initiatives: 
New customer activity is a cornerstone for our growth and I am pleased that we are continuously partnering 
with new customers.  New customer orders received, in 2014, accounted for $0.8 million of the total growth 
across  several  market  sectors,  including:    Glass  Inspection,  Medical  Devices,  Metrology,  Entertainment 
Industry,  Aeronautics,  and  Industrial  Automation  and  Inspection.  In  addition,  several  large  non-recurring 
engineering  (NRE)  orders  received  in  2013  were  completed  in  2014  for  which  we  now  await  production 
orders from these customers based on their go-forward schedules.   

We  continue  to  add  new  customer  opportunities  through  customer  sponsored  development.    Such 
development has resulted in the release of two new products in 2014.  I expect the custom/OEM versions of 
these products will deploy commercially beginning in the second half 2015 with the announced new products 
lines gaining commercial acceptance late in 2015.   

Page 4 

 
 
 
 
 
 
 
 
 
Product development and market development: 
During  the  year,  ProPhotonix  completed  the  development  of  a  multi-channel  compact  fiber-coupled  high 
power UV laser light source (32 channels).  This new capability is now being marketed to the computer-to-
plate (Ctp) and maskless lithography industries.  Our technology roadmap in this area includes:  single-mode 
fiber  coupled  lasers,  multi-spectral  beam  combiners,  multi-channel  beam  combiners,  and  expansion  of  the 
multi-mode  fiber  laser  product. Target  markets  for  future  systems  include  sensing,  such as  optical  sorting, 
medical, and microscopy applications.  Product development initiatives in 2014 also included the release of 
one new laser module and three new LED products.  All in, the ProPhotonix development team announced 
four  new  products  during  2014.  The  New  Year  will  be  even  more  interesting  with  the  release  of  six  new 
products early in the first quarter alone; obviously the team has been very busy developing new products for 
our addressable markets during 2014 which should positively impact 2015 and beyond. 

We  also  continue  to  pursue  our  existing  market  activities.    In  2014,  we  added  eight  new  diodes  to  the 
distribution product line-up.  We also improved our distribution network coverage with the addition of Alava 
Ingenieros S.A. group, representing us in Spain and Portugal.   

Last  year,  I  mentioned  the  UV  LED  market  as  a  high  potential  target  market.    One  of  the  new  products 
released  during  2014  is  the  COBRA  Cure,  one  of  the  several  ProPhotonix  UV  LED  products.    We  are 
currently  working  with  several  potential  customers  to  provide  robust  UV  LED  illuminators  in  markets 
including:  3D printing, pinning in the printing market, and UV curing.  We are very excited about the LED 
UV market and believe the additional markets for these products include:    disinfection, DNA sequencing, 
protein analysis, and drug discovery. 

Growth, Prosperity, the Future 
I  am  happy  with  our  financial  performance,  but  not  nearly  satisfied.    Whilst  the  macroeconomic  and 
notably  foreign  exchange  issues  are  beyond  our  control,  we  are  confident  that  the  work  we  have 
done on new product and customer development will bear fruit.     We remain committed to revenue 
growth through our existing customer base, but also by securing new customers.   We must build on the 2014 
success, furthering new customer revenue, while growing within our existing customer base by helping  all 
customers prosper with ever evolving products for their applications. ProPhotonix’ near-term perspective has 
not  changed,  seeking  sustained  positive:  EBITDA,  cash  flow,  and  net  income.    We  will  accomplish  these 
goals through a relentless focus on cost management and most importantly through revenue growth.   

ProPhotonix’s  growth  in  the  medium-term  will  be  accomplished  with  not  only  new  customer  wins  in  our 
currently served markets, but also through expansion into new markets and with new products.  In addition to 
the  few  important  areas  where  we  are  focused,  we  will  continuously  evaluate  additional  high  growth 
opportunities. 

In conclusion, I remain deeply grateful for the continued support of you my co-workers, and our customers, 
suppliers, service providers, and investors! 

Respectfully submitted, 

Tim Losik 
President and Chief Executive Officer 

Page 5 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Director Remuneration Report 

 For the year ended December 31, 2014 

Executive Director Compensation - Executive Director Compensation is reviewed by the  
Independent Non-Executive Directors.  

Executive Director 

($) 

Bonus ($) 

Salary       

Pension 
($) 

Other (1) 
($) 

Total Cash 
Compensation 
($) 

Options 
($) 

Total ($) 

Total All 
Compensation 
2014 ($) 

Total All 
Compensation 
2013 ($) 

Tim Losik 

300,750  

           -  

      5,750  

-  

306,500  

29,271  

     29,271  

335,771  

270,957  

Total Executive 
Compensation 

Non-Executive Director 

300,750  

           -  

      5,750  

              -  

306,500  

      29,271  

   29,271  

335,771  

270,957  

Ray Oglethorpe 

Timothy Steel 

-  

-  

-  

-  

-  

-  

       25,000  

25,000 

3,507  

3,507  

28,507  

28,731  

       25,000  

25,000 

         3,507  

      3,507  

28,507  

28,731  

Vincent Thompson 

           -  

           -  

           -  

       25,000  

25,000 

         3,507  

      3,507  

28,507  

28,731  

Mark Weidman 

-  

-  

-  

       25,000  

25,000 

3,507  

3,507  

28,507  

16,231  

Total Non-Executive 
Compensation 

Director Share Options: 

           -  

           -  

           -  

100,000  

100,000 

14,028  

14,028  

114,028  

102,424  

Director 

Options @ 
12/31/13 

Options 
Granted 

Options 
Forfeited 

Options @ 
12/31/14 

Tim Losik 

1,400,000  

3,500,000  

                -   

4,900,000  

Ray Oglethorpe 

1,684,006  

150,000  

(25,000)   

1,809,006  

Timothy Steel 

1,145,433  

150,000  

                -   

1,295,433  

Vincent Thompson 

1,145,433  

150,000  

                -   

1,295,433  

Mark Weidman 

700,000  

150,000  

                -   

850,000  

Total All Directors 

6,074,872  

4,100,000  

 (25,000) 

10,149,872  

(1)  Other compensation for non-executive directors represents cash payments expensed in the current year. 

Page 6 

 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
   
   
   
   
   
   
   
   
   
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
   
   
   
  
  
  
  
  
   
   
   
   
  
  
  
  
  
   
   
   
  
  
  
  
  
   
   
   
  
  
  
  
  
   
   
   
  
  
  
  
  
   
   
   
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
(This page left intentionally blank.) 

Page 7 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
ProPhotonix Limited 

Consolidated Financial Statements 

Years Ended December 31, 2014 and 2013 

Page 8 

 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS 

Item 

Page 

Independent Auditor’s Report .......................................................................................................................  

  10  

Consolidated Balance Sheets as of December 31, 2014 and 2013 ...............................................................  

  12  

Consolidated Statements of Operations and Comprehensive Loss for the Years Ended December 31, 

2014 and 2013 ...........................................................................................................................................  

     13 

Consolidated Statements of Stockholders’ (Deficit) for the Years Ended December 31, 2014 and 2013 ...  

     14 

Consolidated Statements of Cash Flows for the Years Ended December 31, 2014 and 2013 .....................  

  15  

Notes to Consolidated Financial Statements……………………………………………………………….     16  

Page 9 

 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Independent Auditors’ Report 

The Board of Directors 
ProPhotonix Limited 
32 Hampshire Road 
Salem 
New Hampshire 
United States of America 

Report on the Financial Statements 

We  have  audited  the  accompanying  consolidated  financial  statements  of  ProPhotonix  Limited  and  its 
subsidiaries, which comprise the consolidated balance sheets as of December 31, 2014 and 2013, and the related 
consolidated  statements  of  operations  and  comprehensive  loss,  stockholders’  (deficit),  and  cash  flows  for  the 
years then ended, and the related notes to the consolidated financial statements. 

This  report  is  made  solely  to  the  company’s  stockholders,  as  a  body,  in  accordance  with  the  terms  of  our 
engagement. Our audit work has been undertaken so that we might state to the company’s stockholders those 
matters  we  have  been  engaged  to  state  to  them  in  this  report  and  for  no  other  purpose.  To  the  fullest  extent 
permitted  by  law,  we  do  not  accept  or  assume  responsibility  to  anyone  other  than  the  company  and  the 
company’s stockholders, as a body, for our audit work, for this report, or for the opinions we have formed. 

Management’s Responsibility for the Financial Statements 

Management is responsible for the preparation and fair presentation of these consolidated financial statements 
in accordance with U.S. generally accepted accounting principles; this includes the design, implementation, and 
maintenance  of  internal  control  relevant  to  the  preparation  and  fair  presentation  of  consolidated  financial 
statements that are free from material misstatement, whether due to fraud or error. 

Auditors’ Responsibility 
Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We 
conducted our audits in accordance with auditing standards generally accepted in the United States of America. 
Those standards require  that we plan and perform the audit to obtain reasonable assurance  about whether the 
consolidated financial statements are free from material misstatement.  

An  audit  involves  performing  procedures  to  obtain  audit  evidence  about  the  amounts  and  disclosures  in  the 
consolidated  financial  statements.  The  procedures  selected  depend  on  the  auditors’  judgment,  including  the 
assessment of the risks of material misstatement of the consolidated financial statements, whether due to fraud 
or  error.  In  making  those  risk  assessments,  the  auditor  considers  internal  control  relevant  to  the  entity’s 
preparation  and  fair  presentation  of  the  consolidated  financial  statements  in  order  to  design  audit  procedures 
that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness 
of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the 
appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by 
management, as well as evaluating the overall presentation of the consolidated financial statements.  

We  believe  that  the  audit  evidence  we  have  obtained  is  sufficient  and  appropriate  to  provide  a  basis  for  our 
audit opinion. 

Page 10 

 
Opinion

In our opinion, the consolidated financial statements referred to above present fairly in all material respects, the 
financial  position  of  ProPhotonix  Limited  and  its  subsidiaries  as  of  December 31,  2014  and  2013,  and  the 
results  of  their  operations  and  their  cash  flows  for  the  years  then  ended  in  accordance  with  U.S. generally 
accepted accounting principles. 

Cambridge 
United Kingdom 
(cid:48)(cid:68)(cid:85)(cid:70)(cid:75)(cid:3)(cid:21)(cid:23)(cid:15)(cid:3)(cid:21)(cid:19)(cid:20)(cid:24)

Page 11

FINANCIAL STATEMENTS 

PROPHOTONIX LIMITED 

CONSOLIDATED BALANCE SHEETS 

 ($ in thousands except share and per share data) 

December 31 

        2014          

        2013          

Assets 
Current assets: 
Cash and cash equivalents 
Accounts receivable, less allowances of $20 in 2014 and $19 in 2013 
Inventories 
Prepaid expenses and other current assets 

Total current assets 
Net property, plant and equipment 
Goodwill 
Acquired intangible assets, net 
Other long-term assets 

Total assets 

Liabilities and Stockholders’(Deficit) 
Current liabilities: 
Revolving credit facility 
Current portion of long-term debt 
Capital lease obligations 
Accounts payable 
Accrued expenses 

Total current liabilities 
Long-term debt, net of current portion 
Other long-term liabilities 

Total liabilities 

Stockholders’ deficit: 
Common stock, par value $0.001; shares authorized 250,000,000 at December 31, 2014 and 

150,000,000 at December 31, 2013; 83,665,402 shares issued and outstanding at December 31, 
2014 and at December 31, 2013 

Additional paid-in capital 
Accumulated deficit 
Accumulated other comprehensive income / (loss) 

Total stockholders’ deficit 

Total liabilities and stockholders’ deficit 

$ 

$ 

331  
2,606  
1,686  
180  

4,803  
184  
429  
-  
206  

402  
2,559  
2,003  
220  

5,184  
303  
486  
102  
354  

$                5,622   

$                6,429   

$ 

$ 

1,140  
770  
-  
1,463  
965  

4,338  
1,641  
178  

6,157  

1,127  
265  
10  
1,542  
1,296  

4,240  
2,445  
178  

6,863  

84  
111,583  
(113,014) 
812  

84  
111,302  
(111,674) 
(146)  

                     (535) 

                     (434)   

$ 

 5,622  

$ 

 6,429  

See the notes to consolidated financial statements.  

Page 12 

 
 
  
 
 
 
  
  
  
 
 
 
  
  
  
  
 
 
 
 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
  
  
 
 
 
 
 
 
 
 
  
  
  
 
 
 
 
 
 
  
  
  
 
 
  
  
  
 
 
 
  
  
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
PROPHOTONIX LIMITED 
Consolidated Statements of Operations and Comprehensive Loss 
($ in thousands except share and per share data) 

Revenue 

Cost of Revenue 

Gross Profit 

Research & Development Expenses 

Selling, General & Administrative Expenses 

Amortization of Intangible Assets 

Operating Income (Loss) 

Other Income / (Expense), net 

Foreign Currency Translation (losses) / gains 

Warrant & Debt Acquisition Expense 

Interest Expense 

Loss Before Taxes 

Tax Benefit 

Net Loss 

Other Comprehensive Income / (Loss): 

     Foreign currency translation 

Total Comprehensive Loss 

Years Ended 
December 31,  

2014 

2013 

$             16,431 
(10,006) 

$             15,599 
(9,628) 

6,425 

(879) 
(5,350) 

(100) 

96 

93 

(1,031) 

(198) 

(300) 

(1,340) 

- 

5,971 

(941) 
(6,091) 

(120) 

(1,181) 

117 

178 

(103) 

(237) 

(1,226) 

73 

  $          ( 1,340) 

$           (1,153) 

958 

(368) 

$          ( 382) 

  $          ( 1,521) 

Loss Per Share: 
Basic and diluted: 

Net loss per share 

Basic and diluted weighted average shares outstanding 

($0.02) 

83,665,402 

($0.01) 

80,496,977 

See the notes to consolidated financial statements.  

Page 13 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PROPHOTONIX LIMITED  
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT  
(in thousands) 

Common Stock  

Shares  

Par 
$0.001  

Additional 
Paid in 
Capital  

Accumulated 
Deficit  

Accumulated 
Other 
Comprehensive 
Income  

Total 
Stockholders’ 
Equity (Deficit) 

Balance December 31, 2012   
Share based compensation, net 
of forfeitures  ................  
Issuance of common stock to 
settle liabilities  ............  

Issuance of warrants for 

financings  ....................  
Translation adjustment ......  
Net loss ..............................  

76,059 

$ 

76  

$110,893  

$ 

(110,521) 

$ 

222  

$ 

- 

7,606 

- 

-  

8  

-  

169  

185  

55  

                - 

                  - 

                - 

                  - 

                - 

(1,153) 

                  - 
(368)  

670  

169  

193  

55  
(368) 
(1,153) 

Balance December 31, 2013   

83,665 

$ 

84  

$111,302  

$ 

(111,674) 

$ 

(146)  

$ 

(434)  

Share based compensation, net 
of forfeitures  ................  
Translation adjustment ......  
Net loss ..............................  

- 

- 

-  

-

280  

                - 

-

                (1,340) 

                  - 
958  

                  - 

280  
958  
(1,340)  

Balance December 31, 2014   

83,665 

$ 

84  

$111,583  

$ 

(113,014) 

$ 

812  

$ 

(535)  

See the notes to consolidated financial statements.  

Values may not add due to rounding 

Page 14 

 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
  
  
  
 
 
 
  
  
 
  
 
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
 
 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
  
  
 
PROPHOTONIX LIMITED  

CONSOLIDATED STATEMENTS OF CASH FLOWS 

(In thousands) 

Years Ended December 31 

2014  

2013 

Cash flows from operating activities 
Net loss 
Adjustments to reconcile net loss to net cash used in operating activities: 

$                                  (1,340)   $                                   (1,153)  

Stock-based compensation expense 
Depreciation and amortization 
Foreign exchange loss / (gain) 
Amortization of debt discount and financing costs 
Loss / (gain) on disposal of assets 
Provision for inventories 
Provision for bad debts 
Other changes in assets and liabilities: 

Accounts receivable 
Inventories 
Prepaid expenses and other current assets 
Accounts payable 
Accrued expenses 
Other assets and liabilities 

Net cash provided by (used in) operating activities 

Investing 
Purchase of property, plant and equipment 

Net cash used in investing activities 

Financing 
Borrowings of revolving credit facilities, net 
Proceeds from issuance of debt 
Principal repayment of long-term debt 
Debt issuance costs 

Net cash provided by financing activities 

Effect of exchange rate on cash 

Net change in cash and equivalents 
Cash and equivalents at beginning of period 

Cash and equivalents at end of period 

Supplemental cash flow information: 
Cash paid for interest 
Common stock issued in connection with financing 
Warrants issued in connection with financing 

280  
258  
1,066  
186  
4  
55  
5 

169  
332  
(408)  
96  
(7)  
120  
(12)  

(395) 
38 
23 
100 
                                        (248)  
(2)  

(222) 
(8) 
20 
(518) 
                                          171  
(9)  

30 

(64) 

(64) 

144  
175  
(292) 
- 

                  27 

                       (64) 

                   (71) 
                  402  

$ 

$ 
$ 
$ 

331  

303  
-  
-  

(1,429) 

(17) 

(17) 

438  
800  
(339) 
(398) 

                  501 

                       69 

                   (876) 
                1,278  

$ 

$ 
$ 
$ 

402  

263  
193  
55  

                                                                           See the notes to consolidated financial statements. 

Page 15 

 
  
 
 
 
  
  
  
  
 
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
 
 
  
  
  
 
 
 
 
  
  
  
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
                                                                        
 
 
 
 
 
PROPHOTONIX LIMITED  

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS  

(1) ORGANIZATION AND BASIS OF PRESENTATION  

ProPhotonix  Limited  (also  referred  to  in  this  document  as  “ProPhotonix”,  “we”,  or  the  “Company”) 
operates in two segments: as an independent designer and manufacturer of LED systems through ProPhotonix 
(IRL)  Limited; and as  a  manufacturer of laser modules  and a distributor  of laser diodes through  ProPhotonix 
Limited,  a  U.K.  subsidiary.  The  operating  units  are  ProPhotonix  (IRL)  Limited  based  in  Cork,  Ireland, 
ProPhotonix Limited, a U.K. subsidiary based near Stansted, United Kingdom and ProPhotonix Limited, based 
in Salem, New Hampshire, U.S.A.  The Company’s products serve a wide range of applications and industries 
including  machine  vision  and  industrial  inspection,  biomedical,  defense  and  security,  and  other  commercial 
applications.  

ProPhotonix Limited was incorporated on March 27, 1951 in the Commonwealth of Massachusetts and 
is currently incorporated in the state of Delaware. The common stock of the Company now trades on the OTC 
Market in the U.S.  under the trading symbol “STKR” and is also  traded on the  London Stock Exchange, plc 
(AIM listing), under the trading symbols “PPIR” and “PPIX”.   

The accompanying consolidated financial statements have been prepared on a going concern basis, which 
contemplates  the  realization  of  assets  and  the  satisfaction  of  liabilities  in  the  normal  course  of  business.  As 
shown  in  the  consolidated  financial  statements,  during  the  years  ended  December 31,  2014  and  2013,  the 
Company  recorded  net  losses  of  $1,340,000  and  $1,153,000,  respectively.    Net  cash  flow  from  operating 
activities  for  the  same  time  periods  were  $30,000  and  $(1,429,000),  respectively.  The  consolidated  financial 
statements  do  not  include  any  adjustments  relating  to  the  recoverability  and  classification  of  recorded  asset 
amounts or the amounts and classification of liabilities that might be necessary should the Company be unable 
to  continue  as  a  going  concern.        The  Company  believes  that  it  has  adequate  available  working  capital  to 
continue to trade for at least the next twelve months from the issuance of these financial statements.   

(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  

The accompanying consolidated financial statements are prepared in conformity with Generally Accepted 
Accounting Principles (“U.S. GAAP”) and reflect the application of the Company’s most significant accounting 
policies  as  described  in  this  note  and  elsewhere  in  the  accompanying  consolidated  financial  statements  and 
notes.  

PRINCIPLES OF CONSOLIDATION  

The accompanying consolidated financial statements include the accounts of the Company and its wholly 
owned  subsidiaries,  ProPhotonix  (IRL)  Limited,  StockerYale  (UK)  Ltd.,  which  owns  100%  of  ProPhotonix 
Limited,  a  U.K.  subsidiary,  and  ProPhotonix  Holdings,  Inc.,  which  holds  all  of  the  outstanding  shares  of 
StockerYale Canada. All intercompany balances and transactions have been eliminated.    

CASH AND CASH EQUIVALENTS  

The Company considers cash equivalents to consist of highly liquid investments with original maturities of 

three months or less when purchased.  

Page 16 

 
 
 
ACCOUNTS RECEIVABLE  

The Company reviews the financial condition of new customers prior to granting credit. After completing 
the credit review, the Company establishes a credit line for each customer. Periodically, the Company reviews 
the credit line for major customers and adjusts the credit limit based upon an updated financial condition of the 
customer, historical sales and payment information and expected future sales. The Company has a large number 
of customers; therefore, material credit risk is limited.  

The Company periodically reviews the collectability of its accounts receivable. Provisions are established 
for  accounts  that  are  potentially  uncollectible.  The  Company  also  has  accounts  receivables  insurance  at 
ProPhotonix  Limited,  a  U.K.  subsidiary,  which  also  covers  most  of  the  larger  customers  at  the  ProPhotonix 
(IRL)  Limited subsidiary, and  allows the Company to  submit a claim  on overdue receivables in excess of 60 
days  past  invoice  due  date.    Determining  adequate  reserves  for  accounts  receivable  requires  management’s 
judgment.  Conditions  impacting  the  collectability  of  the  Company’s  receivables  could  change  causing  actual 
write-offs to be materially different than the reserved balances.  

Changes in the allowance for doubtful accounts were as follows:   

Years Ended December 31 

Balance at beginning of period ..................................................................  
Charges (recoveries) to costs and expenses ..............................................  
Account write-offs and other deductions ..................................................  

Balance at end of period ............................................................................  

2014  
2013  
In thousands 

$ 

19   $ 
3  
(2) 

31  
(10)  
(2) 

$ 

20   $ 

19  

INVENTORY  

The  Company  values  inventories  at  the  lower  of  cost  or  market  using  the  first  in,  first-out  (“FIFO”) 
method. The Company periodically reviews the quantities of inventory on hand and compares these amounts to 
the expected usage for each particular product or product line. The Company records as a charge to cost of sales 
any amounts required to reduce the carrying value amount of the  inventory to market. Actual results could be 
different from management’s estimates and assumptions.  

INTANGIBLE ASSETS  

The  Company’s  intangible  assets  consist  of  goodwill,  trademarks,  acquired  patents  and  patented 
technologies,  distributor  and  customer  relationships  and  related  contracts,  technology  design  and  programs, 
non-compete agreements and other intangible assets which, except for goodwill, are being amortized over their 
useful lives.  Goodwill is tested for impairment on an annual basis, and between annual tests when indicators of 
impairment  are  present,  and  written  down  when  and  if  impaired.    The  Company  has  elected  the  end  of  the 
fourth quarter to complete its annual goodwill impairment test.  

LONG-LIVED ASSETS  

The Company reviews the recoverability of its long-lived assets including property, plant and equipment 
and amortizing intangible assets when events or changes in circumstances occur that indicate that the carrying 
value  of  the  assets  may  not  be  recoverable.  This  review  is  based  on  the  Company’s  ability  to  recover  the 
carrying  value  of  the  assets  from  expected  undiscounted  future  cash  flows.  If  impairment  is  indicated,  the 

Page 17 

 
 
 
 
  
  
  
  
 
 
 
 
  
  
  
  
  
  
 
Company measures the loss based on the difference between the carrying value and fair value of the asset using 
various valuation techniques including discounted cash flows. If the asset is determined not to be recoverable,, 
the amount of the loss will be recorded in the consolidated statements of operations. It is possible that future 
events or circumstances could cause these estimates to change.  

LOSS PER SHARE  

The Company calculates basic and diluted net loss per common share by dividing the net loss applicable to 

common stockholders by the weighted average number of common shares outstanding.  

As of December 31, 2014, 22,365,040 shares underlying options and 8,577,567 shares underlying warrants 

were excluded from the calculation of diluted shares, as their effects were anti-dilutive.  

As of December 31, 2013, 12,615,690 shares underlying options and 8,582,567 shares underlying warrants 

were excluded from the calculation of diluted shares, as their effects were anti-dilutive.  

REVENUE RECOGNITION  

The  Company  recognizes  revenue  from  product  sales  at  the  time  of  shipment  and  when  persuasive 
evidence of an arrangement exists, performance of our obligation is complete, the price to the buyer is fixed or 
determinable,  and collectability is  reasonably  assured.  Custom products are designed  and supplied to original 
equipment  manufacturers  and  produced  in  accordance  with  a  customer-approved  design.  Custom  product 
revenue is recognized when the criteria for acceptance has been met. Title to the product generally passes upon 
shipment,  as  products  are  generally  shipped  free  on  board  at  shipping  point.  In  certain  limited  situations, 
distributors  may  have  the  right  to  return  products.  Such  rights  of  return  may  preclude  the  Company  from 
recognizing revenue until the return period has ended.  

Revenues  from  funded  research  and  development  and  product  development  are  recognized  based  on 
contractual arrangements, which may be based on cost reimbursement or fixed fee-for-service models. Revenue 
from  reimbursement  contracts  is  recognized  as  services  are  performed.  On  fixed-price  contracts,  revenue  is 
generally  recognized  on  a  percentage  of  completion  basis  based  on  proportion  of  costs  incurred  to  the  total 
estimated  costs  of  the  contract.  Over  the  course  of  a  fixed-price  contract,  the  Company  routinely  evaluates 
whether  revenue  and  profitability  should  be  recognized  in  the  current  period.  The  Company  estimates  the 
proportional performance on their fixed-price contracts on a monthly basis utilizing hours incurred to date as a 
percentage of total estimated hours to complete the project. If the Company does not have a sufficient basis to 
measure  progress  toward  completion,  revenue  is  recognized  upon  completion  of  performance,  subject  to  any 
project  management  assessments  as  to  the  status  of  work  performed.  When  the  current  estimates  of  total 
contract revenue and contract costs indicate a loss, a provision for the entire loss on the contract is recorded. 

For  those  arrangements  that  include  multiple  deliverables,  the  Company  first  determines  whether  each 
service  or  deliverable  meets  the  separation  criteria  of  FASB  ASC  605-25,  Revenue  Recognition—Multiple-
Element Arrangements. In general, a deliverable (or a group of deliverables) meets the separation criteria if the 
deliverable  has  stand-alone  value  to  the  customer  and,  if  the  arrangement  includes  a  general  right  of  return 
related to the delivered item, that delivery or performance of the undelivered item(s) is considered probable and 
is  substantially  in  control  of  the Company. Each  deliverable that meets the separation criteria is  considered a 
separate  ‘‘unit  of  accounting”.   After  the  arrangement  consideration  has  been  allocated  to  each  unit  of 
accounting, the Company applies the appropriate revenue recognition method for each unit of accounting based 
on the nature of the arrangement and the services included in each unit of accounting.  All deliverables that do 
not meet the separation criteria of FASB ASC 605-25 are combined into one unit of accounting, and the most 
appropriate revenue recognition method is applied. 

Page 18 

 
  
WARRANTY  

The Company provides standard warranties for most products for periods up to one year. The warranty is 
limited to the cost of the product and the Company will repair or replace the product as required. The Company 
monitors  the  actual  warranty  repair  costs  and  trends  in  relation  to  the  reserve  as  a  percent  of  sales.  The 
Company  adjusts  annually  the  warranty  provision  based  on  actual  experience  and  for  any  particular  known 
instances.  

Warranty Reserves:  

Balance at beginning of period ....................................................  
Charges (recoveries) to costs and expenses .................................  
Account write-offs and other deductions .....................................  

$ 

$ 

In thousands 
146 
36  
(36) 

Balance at end of period ......................................................  

$ 

146 

$ 

164 
(4)  
(14) 

146 

Years Ended December 31,  

    2014      

    2013     

 The Company expenses advertising costs as incurred. Advertising expenses for the years ended 2014 and 

2013 were approximately $82,000 and $181,000, respectively.   

ADVERTISING EXPENSE 

PROPERTY, PLANT AND EQUIPMENT  

Property, plant and equipment are valued at the lower of cost or estimated carrying values. The Company 
provides for depreciation on a straight-line basis over the assets estimated useful lives or capital lease terms, if 
shorter. The following table summarizes the estimated useful lives by asset classification:  

Asset Classification 
Building and building improvements ...................................   Term of the lease or 10-40 years 
Computer equipment ............................................................  
Machinery and equipment ....................................................  
Furniture and fixtures ...........................................................  

3 to 5 years  
5 to 10 years  
3 to 10 years  

Estimated Useful Life  

Maintenance and repairs are expensed as incurred.  

INCOME TAXES  

The  Company  accounts  for  income  taxes  under  the  asset  and  liability  method.  Under  this  method  the 
Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that 
have been recognized in the financial statements or tax returns. Deferred tax assets and liabilities are determined 
based on the difference between the financial reporting and tax basis of the assets and liabilities using tax rates 
expected to be in place when the differences reverse. Valuation allowances are established when necessary to 
reduce deferred tax assets to the amount that is more likely than not to be realized.   The Company recognizes 
the  tax  benefit  of  tax  positions  to  the  extent  that  the  benefit  will  more  likely  than  not  be  realized.  The 
determination  as  to  whether  the  tax  benefit  will  more  likely  than  not  be  realized  is  based  upon  the  technical 

Page 19 

 
  
  
  
  
  
  
  
  
 
 
 
 
  
  
  
  
  
  
  
 
 
  
  
 
 
 
merits of the tax position as well as consideration of the available facts and circumstances.   With respect to any 
uncertain  tax  positions,  the  Company  records  interest  and  penalties,  if  any,  as  a  component  of  income  tax 
expense.  It  did  not  have  any  interest  and  penalties  related  to  uncertain  tax  positions  during  the  years  ended 
December 31, 2014 or 2013.   

STOCK-BASED COMPENSATION  

the  grant  of  a  variety  of  awards  with  various 

The  Company  has  stock-based  compensation  plans  for  its  employees,  officers,  and  directors.  The  plans 
permit 
the  
Remuneration Committee of the Company’s Board of Directors. Generally the grants vest over terms of one to 
four years and are priced at fair market value, or in certain circumstances 110% of the fair market value, of the 
common  stock  on  the  date  of  the  grant.  The  options  are  generally  exercisable  after  the  period  or  periods 
specified in the option agreement, but no option may be exercised after 10 years from the date of grant.  

terms  and  prices  as  determined  by 

Additionally, in the case of incentive stock options, the exercise price may not be less than 100% of the 
fair  market  value  of  the  Company’s  common  stock  on  the  date  of  grant,  except  in  the  case  of  a  grant  to  an 
employee who owns or controls more than 10% of the combined voting power of all classes of the Company’s 
stock or the stock of any parent or subsidiary. In that case, the exercise price shall not be less than 110% of the 
fair market value on the date of grant. In the case of non-qualified stock options, the exercise price shall not be 
less than 85% of the fair market value of the Company’s common stock on the date of grant, except in the case 
of  a  grant  to  an  independent  director;  in  which  case  the  exercise  price  shall  be  equal  to  fair  market  value 
determined by reference to market quotations on the date of grant.  

During  2014,  the  Company  recognized  approximately  $280,000  of  stock-based  compensation  related  to 
options, all of which was charged to general and administrative expense. During 2013, the Company recognized 
approximately $169,000  of  stock-based  compensation related to options,  all  of which was  charged to  general 
and administrative expense.  

Stock  Option  Awards—The  fair  value  of  each  option  grant  is  estimated  using  the  Black-Scholes  option 
pricing model. The fair value is then expensed ratably over the requisite service periods of the awards, which is 
generally the vesting period. Use of a valuation model requires management to make certain assumptions with 
respect  to  selected  model  inputs.  Expected  volatility  is  calculated  based  on  the  historical  volatility  of  the 
Company’s stock at the time of the award. The average expected option term is based on historical trends. The 
risk-free interest rate is based on U.S. Treasury zero-coupon issues assumed at the date of grant and generally 
no dividends are assumed in the calculation. The compensation expense recognized for all equity-based awards 
is net of estimated forfeitures. Forfeitures are estimated based on the historical trends. 

During 2014, the Company implemented the 2014 stock incentive plan, which is described in Note 11. 

TRANSLATION OF FOREIGN CURRENCIES  

The Company’s operating results are affected by fluctuations in the value of the U.S. dollar as compared to 
currencies in foreign countries, as a result of our transactions in these foreign markets.  For foreign subsidiaries, 
whose functional currency is not the U.S. dollar, assets and liabilities are translated using the foreign exchange 
rates prevailing at the balance sheet date, and income and expense accounts using average exchange rates for 
the period. Cumulative transaction gains or losses from the translation into the Company’s reporting currency 
are included as a separate component of stockholder’s deficit (accumulated other comprehensive income) in the 
accompanying consolidated balance sheets.  

Page 20 

 
  
  
 
 
 
 
Management  determined  the  functional  currency  of  ProPhotonix  Limited,  a  U.K.  subsidiary,  and 
ProPhotonix (IRL) Limited is the euro, while the functional currency of ProPhotonix Limited U.S.A. is the U.S. 
dollar. 

FAIR VALUES OF FINANCIAL INSTRUMENTS  

The Company’s financial instruments consist mainly of cash and cash equivalents, accounts receivable, 
revolving  credit  facility,  accounts  payable  and  long-term  debt.  The  estimated  fair  value  of  these  financial 
instruments, with the exception of fixed rate long-term debt, approximates their carrying value due to the short-
term maturity of certain  instruments and the variable interest  rates  associated  with  certain  instruments,  which 
have the effect of re-pricing such instruments regularly. 

At December 31, 2014, the Company estimated the fair value of long term fixed rate debt to be 

approximately $3,300,000 compared to its carrying value of $3,100,000. 

CONCENTRATION OF CREDIT RISK  

Financial  instruments  that  potentially  subject  the  Company  to  concentrations  of  credit  risk  consist 
principally of trade receivables. The risk is limited due to the relatively large number of customers composing 
the  Company’s  customer  base  and  their  dispersion  across  many  industries  and  geographic  areas  within  the 
United States, Canada, United Kingdom, Europe and Asia. The Company performs ongoing credit evaluations 
of existing customers’ financial condition. The Company believes that its concentrated credit risk is limited to 
only a small number of customers. The Company had no customer accounting for 10% or more of consolidated 
revenues in either 2014 or 2013.  The Company had one customer that accounted for 10% of the outstanding 
accounts  receivable  balance  at  December 31,  2014  and  2013.  The  Company  maintains  its  cash  and  cash 
equivalents  in  bank  deposit  accounts, which at times may  exceed insured limits.   At December  31, 2014, the 
amount  in  excess  of  governmental  insurance  protection  was  approximately  $0.2  million,  measured  across  all 
entities and jurisdictions.  At December 31, 2013, the amount in excess of governmental insurance protection 
was approximately $0.3 million.  The Company believes it is not exposed to any significant credit risk on cash 
and cash equivalents. 

USE OF ESTIMATES 

The  preparation  of  financial  statements  in  conformity  with  generally  accepted  accounting  principles 
requires  management  to  make  estimates  and  assumptions  that  affect  the  reported  amounts  of  assets  and 
liabilities  and  disclosure  of  contingent  assets  and  liabilities  as  of  the  date  of  the  financial  statements  and  the 
reported amounts of income and expenses during the reporting periods. Actual results in the future could vary 
from the amounts derived from management’s estimates and assumptions.  

Page 21 

 
 
 
  
 
 
 
 
 
 
 
 
 
 
(3) RECENT ACCOUNTING PRONOUNCEMENTS 

The  Company  has  reviewed  recently  issued  accounting  pronouncements  to  determine  the  impact  that  these 
pronouncements are expected to have on the financial statements when adopted in future periods. 

In August 2014, the FASB updated the Accounting Standards Codification and amended Subtopic 205-
40, Presentation of Financial Statement – Going Concern.  This amended guidance requires that in connection 
with  preparing  financial  statements  for  each  annual  and  interim  reporting  period,  an  entity’s  management 
should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt 
about  the  entity’s  ability  to  continue  as  a  going  concern  within  one  year  after  the  date  that  the  financial 
statements are issued (or within one year after the date that the financial statements are available to be issued 
when applicable). 

Management’s  evaluation  should  be  based  on  relevant  conditions  and  events  that  are  known  and  reasonably 
knowable  at  the  date  that  the  financial  statements  are  issued  (or  at  the  date  that  the  financial  statements  are 
available to be issued when applicable). 

Substantial doubt about an entity’s ability to continue as a going concern exists when relevant conditions and 
events,  considered  in  the  aggregate,  indicate  that  it  is  probable  that  the  entity  will  be  unable  to  meet  its 
obligations  as  they  become  due  within  one  year  after  the  date  that  the  financial  statements  are  issued  (or 
available to be issued).  The term probable is used consistently with its use in Topic 450, Contingencies. 

When  management  identifies  conditions  or  events  that  raise  substantial  doubt  about  an  entity’s  ability  to 
continue as a going concern, management should consider whether its plans that are intended to mitigate those 
relevant  conditions  or  events  will  alleviate  the  substantial  doubt.    The  mitigating  effect  of  the  management’s 
plans  should  be  considered  only  to  the  extent  that  (1)  it  is  probable  that  the  plans  will  be  effectively 
implemented  and,  if  so  (2)  it  is  probable  that  the  plans  will  mitigate  the  conditions  or  events  that  raise 
substantial doubt about the entity’s ability to continue as a going concern. 

If conditions or events raise substantial doubt about an entity’s ability to continue as a going concern, but the 
substantial  doubt  is  alleviated  as  a  result  of  consideration  of  management’s  plans,  the  entity  should  disclose 
information that enables users of the financial statements to understand all of the following: 

a.  Principal conditions or events that raised substantial doubt about the entity’s ability to continue as a 

going concern (before consideration of management’s plans) 

b.  Management’s evaluation of the significance of those conditions or events in relation to the entity’s 

ability to meet its obligations 

c.  Management’s plans that alleviated substantial doubt about the entity’s ability to continue as a going 

concern. 

If  conditions  or  events  raise  substantial  doubt  about  an  entity’s  ability  to  continue  as  a  going  concern,  and 
substantial  doubt  is  not  alleviated  after  consideration  of  management’s  plans,  an  entity  should  include  a 
statement  in  the  footnotes  indicating  that  there  is  substantial  doubt  about  the  entity’s  ability  to  continue  as  a 
going concern within one year after the date that the financial statements are issued (or available to be issued).  
Additionally, the entity should disclose information that enables users of the financial statements to understand 
all of the following: 

a.   Principal conditions or events that raise substantial doubt about the entity’s ability to continue as a 

going concern 

b.  Management’s evaluation of the significance of those conditions or events in relation to the entity’s 

ability to meet its obligations 

Page 22 

 
 
 
 
 
 
 
 
c.  Management’s plans that are intended to mitigate the conditions or events that raise substantial doubt 

about the entity’s ability to continue as a going concern. 

The  amendments  are  effective  for  the  annual  period  ending  after  December  15,  2016,  and  for  annual  periods 
and  interim  periods  thereafter.    Early  application  is  permitted.    The  Company  will  evaluate  this  reporting 
requirement and adopt with the year beginning January 1, 2016.  However the adoption of these requirements is 
not expected to have a significant impact on the Company’s financial statements. 

In  June,  2014,  the  FASB  updated  the  Accounting  Standards  Codification  and  amended  Topic  718, 
Compensation  –  Stock  Compensation.    This  amended  guidance  requires  that  a  performance  based  target  that 
affects  vesting  and  that  could  be  achieved  after  the  requisite  service  period  be  treated  as  a  performance 
condition.    The  reporting  entity  should  apply  existing  guidance,  in  Topic  718,  as  it  relates  to  awards  with 
performance  conditions  that  affect  vesting  to  account  for  such  awards.    As  such,  the  target  should  not  be 
reflected in the estimating the grant-date fair value of the award.  Compensation cost should be recognized in 
the period in which it becomes probable that the performance target will be achieved and should represent the 
compensation cost attributable to the period(s) for which the requisite service has already been rendered.  If the 
performance  target  becomes  probable  of  being  achieved  before  the  end  of  the  requisite  service  period,  the 
remaining  unrecognized  compensation  cost  should  be  recognized  prospectively  over  the  remaining  requisite 
service period.  The total amount of compensation cost recognized during and after the requisite service period 
should reflect the number of awards that are expected to vest and should be adjusted to reflect those awards that 
ultimately vest.  The requisite service period ends when the employee can cease rendering service and still be 
eligible to vest in the award if the performance target is achieved. The adoption of this guidance did not have an 
impact on our consolidated financial position, results of operation or cash flows. 

In May 2014, the FASB amended the Accounting Standards Codification and created a new Topic 606, 
Revenue from Contracts with Customers. The new guidance establishes a single comprehensive contract-based 
model  for  entities  to  use  in  accounting  for  revenue  arising  from  contracts  with  customers.  The  new  model 
significantly changes existing GAAP, requires substantial judgment in its application, and will generally require 
companies  to  make  more  disclosures  about  revenue.  The  core  principle  of  the  amendment  is  that  an  entity 
recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects 
the consideration to which the entity expects to be entitled in exchange for those goods or services. In applying 
the  new  guidance,  an  entity  will  (1)  identify  the  contract(s)  with  a  customer;  (2)  identify  the  performance 
obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the contract’s 
performance obligations; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. 
The new standard provides for two alternative implementation methods. The first is to apply the new standard 
retrospectively  to  each  prior  reporting  period  presented.  This  method  does  allow  the  use  of  certain  practical 
expedients. The second method is to apply the new standard retrospectively in the year of initial adoption and 
record a cumulative effect adjustment for the impact of adjusting contracts open at the date of adoption. Under 
this transition method,  we would apply this  guidance retrospectively only to  contracts that  are not completed 
contracts at the date of initial application. We would then recognize the cumulative effect of initially applying 
the  standard  as  an  adjustment  to  the  opening  balance  of  retained  earnings.  This  method  also  requires  us  to 
disclose comparative information for the year of adoption. We will adopt the FASB’s amended guidance for our 
year beginning January 1, 2016; early adoption is not permitted. We are currently evaluating the new guidance 
and have not determined the impact this standard may have on our financial statements nor have  we decided 
upon the method of adoption. 

Page 23 

 
 
 
 
 
 
 
 (4) INVENTORIES  

Inventories are stated at the lower of cost (first-in, first-out basis) or market when applicable and include 

materials, labor and overhead. Inventories are as follows:  

Years Ended December 31 

Finished goods...................................................................................... 
Work in-process ................................................................................... 
Raw materials ....................................................................................... 

Net inventories ............................................................................. 

2014  

2013 

In thousands 

$      327  
226  
1,133  

$   1,686  

$      403  
218  
1,382  

$   2,003  

Management  performs  quarterly  reviews  of  inventory  and  disposes  of  items  not  required  by  their 

manufacturing plan and reduces the carrying cost of inventory to the lower of cost or market.  

(5) PROPERTY, PLANT AND EQUIPMENT  

Major classes of property, plant and equipment were as follows:  

Years Ended December 31 

2014  

2013  

Buildings and building improvements ...........................................  
Computer equipment ......................................................................  
Machinery and equipment ..............................................................  
Furniture and fixtures .....................................................................  

Property, plant and equipment................................................  
Less accumulated depreciation .......................................................  

Net property, plant and equipment .........................................  

$ 

In thousands 
$ 

276  
413  
1,668  
410  

301  
437  
1,843  
523  

$      2,767 
  (2,583) 

$      3,104 
 (2,801) 

$        184   

$        303   

 Depreciation  expense  from  operations  was  approximately  $158,000  and  $212,000  in  the  years  ended 

December 31, 2014 and 2013, respectively.   

(6) GOODWILL  

 The  Company  uses  a  three-step  approach  to  a  goodwill  impairment  test.    First,  ASU  2011-08  allows 
entities with the option to first use an assessment of qualitative factors to determine whether the  existence of 
events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting 
unit is less than its carrying amount. If a conclusion is reached that reporting unit fair value is not more likely 
than  not  below  carrying  value,  no  further  impairment  testing  is  necessary.  If  further  testing  is  necessary,  the 
second step is to estimate the fair value of its reporting units by using forecasts of discounted cash flows and 
compare  that  value  to  the  carrying  value  which  requires  that  certain  assumptions  and  estimates  be  made 
regarding  industry  economic  factors  and  future  profitability  of  reporting  units  to  assess  the  need  for  an 
impairment charge.  The methodology the Company uses to allocate certain corporate expenses is based on each 
segment’s  use  of  services  and/or  direct  benefit  to  its  employees.  While  the  Company  believes  it  has  made 
reasonable estimates and assumptions to calculate the fair value of the reporting segments and implied fair value 
of  goodwill,  the  impairment  analysis  is  highly  sensitive  to  actual  versus  forecast  results.    Finally,  if  the 

Page 24 

 
  
 
 
  
  
  
  
 
 
 
 
  
  
  
  
  
  
 
  
  
  
  
  
 
 
 
 
 
 
  
  
  
 
 
  
  
  
  
  
  
 
estimated value is less than the carrying value, an impairment loss is recognized for any excess of the carrying 
amount of the reporting unit’s goodwill over the implied fair value of that goodwill. 

In connection with the annual fair value test of goodwill, performed at the end of the fourth quarter 2014, 

and at the end of the fourth quarter 2013, the Company concluded that no impairment existed. 

The changes in the carrying amount of goodwill for the years ended December 31, 2014 and 2013 were as 

follows:  

Beginning of the year ..................................................  
Effect of exchange rate ...............................................  

$                  486   
(57)  

$                  467   
19  

End of year ..................................................................  

$                  429  

$                  486  

December 31, 2014  

December 31, 2013 

( In thousands) 

Goodwill as of December 31, 2014 and 2013 relates to the LED reporting unit. 

(7) INTANGIBLE ASSETS 

Intangible assets consist of distributor and customer relationships and related contracts, technology design 
and programs, and other intangible assets. There are no intangible assets with indefinite lives.   There were no 
intangible assets acquired in 2014.  Intangible assets and their respective useful lives are as follows:  

Acquired customer contracts and relationships 
Acquired technology design and programs 
Other 

Useful Life 
        5 – 8 Years  
8 Years  
        3 – 7 Years 

Gross carrying amounts and accumulated amortization of intangible assets were as follows as of 

December 31, 2014 for each intangible asset class.   

Gross 
Carrying 
Amount  

Accumulated 
Amortization 
(in thousands)    

Net Balances 

Acquired customer contracts and relationships .........................  
Acquired technology design and programs................................  
Other ..........................................................................................  
Total ...................................................................................  

  1,942  
329  
107  
$  2,378   $ 

(1,942) 
            (329) 
(107) 
(2,378) 

$ 

-  
-  
-  
-  

Gross carrying amounts and accumulated amortization of intangible assets were as follows as of 

December 31, 2013 for each intangible asset class.   

Page 25 

 
  
 
  
  
  
  
  
 
 
  
  
  
  
  
 
 
 
 
 
 
 
  
  
 
 
 
  
 
 
 
  
   
 
 
 
 
 
  
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
 
 
 
 
 
Gross 
Carrying 
Amount  

Accumulated 
Amortization  
(in thousands)    

Net Balances 

Acquired customer contracts and relationships .........................  
Acquired technology design and programs ...............................  
Other ..........................................................................................  
Total ...................................................................................  

  2,062  
349  
114  
$  2,525   $ 

(2,011) 
            (298) 
(114) 
(2,423) 

$ 

51  
51  
-  
102  

Actual Expense  

2013  

2014  

     In thousands 

Amortization expense of 

intangible assets ................... $  118  

$  100  

(8) DEBT  

Years Ended December 31 

Senior Fixed Rate Secured Bond (“PPI Bond”) to a private 
investor, maturing on June 30, 2017 with an interest rate 
of 8%, net of unamortized debt discount of $26,000 at 
December 31, 2014 and $45,000 at December 31, 2013, 
with an interest rate of 8%. 

Senior Fixed Rate Secured Bond to a private investor, maturing 

on June 20, 2017, with an interest rate of 12.25%, at 
December 31, 2014 and at December 31, 2013. 

Senior Fixed Rate Secured Bond to a private investor, maturing 

on June 20, 2017,  with an interest rate of  12.25%, at 
December 31, 2014 and at December 31, 2013 

2014(1)  

2013  

In thousands 

$  1,408  

$  1,750   

334  

          320   

        669 

640    

Borrowings under Revolving Credit facility with Barclays Bank Sales 

Financing with an interest rate of 2.50% above Barclay’s base rate at 
December 31, 2014 and at December 31, 2013 (3.0% as of December 31, 
2014 and at December 31, 2013). 

Sub-total debt 

Less – revolving credit facility  
Less—Current portion of long-term debt 

Total long-term debt 

           1,140  

              3,551  
            (1,140)  
               (770)  

1,127    

    3,837   
           (1,127)  
              (265)  

$    1,641  

$   2,445   

  (1) As of December 31, 2014, the Company had approximately $ 1,872,000 available under the various 
borrowing facilities. 

Page 26 

 
  
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
  
Photonic Products Ltd.  

BORROWING AGREEMENTS  

StockerYale (UK) Ltd., a wholly owned subsidiary of the Company, issued bonds to each of the former 
stockholders of Photonic Products Ltd. with an aggregate initial principal amount equal to $2,400,000 (Photonic 
Bonds).  During  the  term  of  the  Photonic  Bonds,  the  Company  and  the  bond  holders  entered  into  various 
amendments and Deeds of Variation.  The bonds were paid in full on April 30, 2013. 

Private Investor Notes and Bond  

ProPhotonix (IRL) Limited Senior Fixed Rate Secured Bond  

On July 24, 2008, ProPhotonix (IRL) Limited issued a three-year 12% Senior Fixed Rate Secured Bond 
(“PPI  Bond”),  as  amended  at  various  times,  to  a  bondholder  in  the  original  principal  amount  of  €935,000 
($1,472,905 at July 24, 2008) secured by all of the assets of ProPhotonix (IRL) Limited.  

On June 20, 2013 the bondholder entered into an amendment and waiver agreement with the Company 
waiving all events of default from inception of the bond through the date of the amendment.  In addition, the 
bondholder also agreed to amend the terms of the bond as follows: 

(a)  Convert  €  144,324  ($193,132)  of  the  balance  of  the  bond  into  common  stock  of  the  Company  with  a 
subsequent transfer of such common stock to the Term Loan holder, described below as part of the Term 
Loan provided to the Company 

(b) Issue 1,900,000 warrants over common stock of the Company exercisable at a price of $0.03 per share 
through  June  20,  2023  as  described  in  Note  10.  The  fair  value  of  these  warrants  of  $55,185  was 
deducted from the carrying value of the bond and is being amortized over the remaining term of the PPI 
Bond 

(c)  Principal as of June 20, 2013:  

€ 1,426,540 ($1,909,281) 

(d) Interest Rate:   

8% per annum 

(e)  Interest payments only: 

June 30, 2013 through June 30, 2014 

(f)  Principal Repayment:  

€15,000  per  month  plus  interest  July  1,  2014  through  June  30, 
2015, thereafter principal and interest monthly  €56,378 ($75,456) from July 1, 2015 through June 30, 
2017* 

(g) One-time fee of €31,413 ($42,043) payable on June 30, 2017.  This fee is being accrued ratably over the 
life  of  the  loan,  payable  in  June,  2017.    In  addition,  the  Company  recorded  debt  acquisition  costs  of 
$134,484 which is being amortized over the life of the amended term note. 

(cid:13) 

In addition to the terms above, the bondholder will be entitled to accelerated principal payments, on a 
quarterly basis, equal to 30% of Free Cash Flow (defined as earnings before interest, taxes, depreciation, 
and  amortization  (EBITDA)  minus  debt  repaid  and  interest  paid,  minus  capital  expenditures  not 
financed,  and  minus  taxes  paid,  each  during  such  calendar  quarter).  Such  payments  have  been  made 
within 45 days of the end of such calendar quarter, or as agreed to by the lender. 

At December 31, 2014, $1,433,877 remained outstanding under the note, which has been classified as 
$420,992  current  portion  of  long  term  debt  and  $1,012,885  long  term  debt  and  reported  net  of  $25,648  of 
unamortized debt discount, which has been reported as $16,190 as short-term and $9,458 as long-term. 

Page 27 

 
 
 
 
 
 
 
 
 
At December 31, 2013, $1,794,702 remained outstanding under the note, which has been classified as 
$123,912  current  portion  of  long  term  debt  and  $1,670,790  long  term  debt  and  reported  net  of  $44,857  of 
unamortized debt discount, which has been reported as $19,209 as short-term and $25,648 as long-term. 

Term Notes: 

PPI Bond Holder   

On June 20, 2013, the Company entered into a Term Loan agreement with the PPI Bond holder to provide 

up to $1.0 million of loan availability subject to certain terms as follows: 

(a)  Available Loan (subject to (b) below): 
(b) 50% of each advance shall be used to repay amounts owed under the PPI Bond  

$1.0 million 

(c)  Interest Rate:   

(d) Interest payments only: 
(e)  Principal Repayment term:  

12.25% per annum 

June 30, 2013 through June 30, 2014 
36 months (July 1, 2014 through June 20, 2017) 

The Company recorded debt acquisition costs of $70,437 which is being amortized over the life of the term 
note.  In addition, the Company is accruing a back-end fee of $15,000 ratably over the life of the loan, payable 
in June, 2017. 

At  December 31,  2014,  $334,486  remained  outstanding  under  the  note,  which  has  been  classified  as 
$121,711  current  portion  of  long-term  debt  and  $212,775  as  long  term  debt.    As  of  December  31,  2014,  the 
Company had net available funding of $305,000. 

At  December 31,  2013,  $320,000  remained  outstanding  under  the  note,  which  has  been  classified  as 
$53,415  current  portion  of  long-term  debt  and  $266,585  as  long  term  debt.    As  of  December  31,  2013,  the 
Company had net available funding of $340,000. 

Tiger Investments 1 LLC 

On June 20, 2013, the Company entered into a Term  Loan agreement with a  Lender, which is owned 
and controlled by the wife of Tim Losik, Patricia Losik. As Mr. Losik is a director and the Chief Executive of 
the Company, the entry into the Loan Facility constitutes a “related party transaction” for the purposes of AIM 
Rule 13. 

The Term Loan provides availability to the Company of up to $2.0 million during the term of the Loan, 

as follows, subject to certain restrictions: 

(a)  Available Loan: 

(b) Interest Rate: 

$2.0 million 

12.25% per annum 

(c)  Interest payments only: 
(d) Principal Repayment term:  

June 30, 2013 through June 30, 2014 
36 months (July 1, 2014 through June 20, 2017) 

The Company recorded debt acquisition costs of $165,817 which is being amortized over the life of the 
term note.  In addition, the Company is accruing a back-end fee of $60,000 over the life of the loan, payable in 
June, 2017. 

Page 28 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At  December 31,  2014,  $668,973  remained  outstanding  under  the  note,  which  has  been  classified  as 
$243,422  current  portion  of  long-term  debt  and  $425,551  as  long  term  debt.    As  of  December  31,  2014,  the 
Company had $1,220,000 available under this borrowing facility. 

At  December 31,  2013,  $640,000  remained  outstanding  under  the  note,  which  has  been  classified  as 
$106,830  current  portion  of  long-term  debt  and  $533,170  as  long  term  debt.    As  of  December  31,  2013,  the 
Company had $1,360,000 available under this borrowing facility. 

Barclays Bank, PLC  

On  February 6,  2008,  ProPhotonix  Limited,  a  U.K.  subsidiary,  entered  into  a  Confidential  Invoice 
Discounting Agreement, as amended at various times, with Barclays Bank Sales Financing (“Barclays”). Under 
the Discounting Agreement, a three-year revolving line of credit was established. The Discounting Agreement 
originally  provided  for  a  revolving  line  of  credit  not  to  exceed  an  aggregate  principal  amount  of  £700,000 
($1,087,000),  later  reduced  to  £650,000  ($1,010,000),  and  grants  a  security  interest  in  and  lien  upon  all  of 
ProPhotonix Limited, a U.K. subsidiary, trade receivables in favor of Barclays. The Company originally could 
borrow  a  total  amount  at  any  given  time  up  to  ₤700,000,  limited  to  qualifying  receivables  as  defined.  The 
facility requires the maintenance of certain financial covenants including a minimum tangible net worth.  

On November 29, 2013, the Company entered into an amendment to the revolving credit facility to (i) 
increase the line from £650,000 to £1,400,000; (ii) to reduce the discount rate from 2.65% plus Barclays base 
rate to 2.50% plus Barclays base rate and service charges and extended the minimum period of this amendment 
to 24 months through November 29, 2015.  The Company recorded debt acquisition costs of $27,172 which is 
being amortized over the two year amendment period. 

The amount outstanding under the facility was $1,140,000 as of December 31, 2014 and $1,127,000 as 
of December 31, 2013, all of which was classified as  a short term debt under revolving credit facility.   As of 
December 31, 2014, the Company had approximately $347,000 available under this facility.    

 (9) TAXES  

The  Company  had  deferred  tax  assets,  before  considering  the  full  valuation  allowance,  totaling 
approximately  $27.1  million  as  of  December 31,  2014  and  approximately  $27.3  million  as  of  December  31, 
2013.  Realization  of  the  deferred  tax  assets  is  dependent  upon  the  Company’s  ability  to  generate  sufficient 
future taxable income and, if necessary, execution of tax planning strategies.    

The Company’s historical operating losses raise considerable doubt as to when, if ever, any of the deferred 
tax assets will be realized. As a result, management has provided a valuation allowance for the net deferred tax 
assets.  In  the  event  management  determines  that  sufficient  future  taxable  income  may  be  generated  in 
subsequent  periods  and  the  previously  recorded  valuation  allowance  is  no  longer  needed,  the  Company  will 
decrease the valuation allowance by providing an income tax benefit in the period that such a determination is 
made. Because of its historical operating losses, the Company has not been subject to income taxes since 1996. 

The Company is subject to taxation in the U.S.,  Canada, the United Kingdom, Ireland and various states 
and local jurisdictions. As a result of the Company’s tax loss position, the tax years 2000 through 2013 remain 
open to examination by the federal and most state tax authorities. In addition, the tax years 2007 through 2013 
are open to examination in foreign jurisdictions. During 2014, the Company’s 2012 tax return was audited by 
the Internal Revenue Service.  As of December 31, 2014, this audit is complete, with no effective change in our 
‘as filed’ 2012 return. 

Page 29 

 
 
 
  The following is a reconciliation of the federal income tax provision calculated at the statutory rate of 

34% to the recorded amount:  

Years Ended December 31, 
Loss before taxes ...............................................................................   
Reconciliation 
Applicable statutory federal income tax benefit ................................  
Foreign tax rate differential ...............................................................  
Non deductible items .........................................................................  
Valuation allowance ..........................................................................  

2014 

2013  

In thousands 

$  (1,340)  $  (1,226) 

(456) 
292 
38  
126 

(417) 
230 
84  
30  

Net income tax provision ...........................................................  

$ 

-  

$ 

(73)  

     The significant items comprising the deferred tax asset and liability at December 31, 2014 and 2013 are as 
follows: 

Years Ended December 31, 

2014  

2013  

              In Thousands 

   Net operating loss carry forwards ...............................................  
   Foreign net operating loss carry forwards ...................................  
   R&D tax credit ............................................................................  
   Other ............................................................................................  
   Valuation allowance ....................................................................  
Total .......................................................................................  

 $      25,160 
           1,602 
              525 
              278 
       (27,565) 
$             -  

 $      25,010 
           1,611 
              525 
              124 
       (27,270) 
$             -  

As  of  December 31,  2014,  the  Company  had  United  States  federal  net  operating  loss  carry  forwards 
(NOLs) of approximately $62.2 million (2013: $62.5 million) available to offset future taxable income, if any.  
These  carry  forwards  expire  through  2034  and  are  subject  to  review  and  possible  adjustment  by  the  Internal 
Revenue  Service.  The  Company  may  be  subject  to  limitations  under  Section 382  of  the  Internal  Revenue 
Service Code as a result of changes in ownership. The Company’s historical operating losses raise considerable 
doubt as to when, if ever, any of the deferred tax assets will be realized. As a result, management has provided a 
full valuation allowance for the net deferred tax assets.  At December 31, 2014, the Company also has Canadian 
federal NOLs of approximately $1.5 million  (2013:  $1.5  million)  available to offset future taxable income, if 
any.  These  carry  forwards  expire  through  2031  and  are  subject  to  review  and  possible  adjustment  by  the 
Canadian Revenue Agency. The Company may be subject to limitations of the use of the Canadian NOLs as a 
result  of  changes  in  ownership.  At  December  31,  2014,  the  Company  also  has  a  United  Kingdom  NOL  of 
approximately $4.6 million (2013: $4.6 million) for which management has provided a full valuation allowance 
against.  At December 31, 2014, the Company also has an Ireland NOL of approximately $2.6 million (2013: 
$2.3  million)  for  which  management  has  provided  a  full  valuation  allowance  against.    The  total  valuation 
allowance against deferred tax assets increased by $0.3 million (2013: decreased by $0.4 million). 

Page 30 

 
 
 
 
 
 
  
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
 
 
 
 
  
  
  
 
 
 
 
 
The Company must determine whether it is more-likely-than-not that a tax position will be sustained upon 
examination, including resolution of any related appeals or litigation processes, based on the technical merits of 
the  position.  A  tax  position  that  meets  the  more-likely-than-not  threshold  is  then  measured  to  determine  the 
amount of benefit to recognize in the financial statements.  As of December 31, 2014 and 2013, the Company 
has cumulatively recorded long-term liabilities of $178,000 and $178,000 respectively, relative to the sale of its 
North American operations to Coherent, Inc. This represents the only significant uncertain tax position of the 
Company. 

(10) UNREGISTERED SALES OF EQUITY SECURITIES AND WARRANTS 

On  June  20,  2013,  €144,324  ($193,132)  of  the  PPI  Bond  (Note  8)  was  converted  in  exchange  for 
7,605,946 shares of common stock of the Company; such shares were issued to the Term Loan holder in partial 
consideration relating to securing the Term  Loan.  Also on June 20, 2013, the Company issued a Warrant in 
partial consideration for the Term Loan issued by the PPI Bond holder, described in Note 8.  The Warrant for 
1,900,000 shares of common stock of the Company is exercisable at a price of $0.03 per share through June 20, 
2023. 

Warrants 

As of December 31, 2014, there were 8,577,567 common shares outstanding warrants with the following 

exercise prices and expiration dates:  

Number of Common Shares 
Warrants 
            551,500 
         3,570,000 
         1,150,000 
            906,067 
            500,000 
         1,900,000  

         8,577,567 

Exercise Price  

Expiration Date  

$0.32 –$1.44  
$1.15 –$3.12  
$0.80 –$1.72  
$0.45 –$0.60  
$0.10 –$0.10  
$0.03  

2015 
2016 
2017 
2018 
2019 
2023 

On June 9, 2014, the Company implemented the creation of a 2014 stock incentive plan. 

(11) STOCK OPTION PLANS  

New remuneration policy for senior management 
Summary 
In  order  to  incentivize  the  achievement  of  its  objectives,  the  Company  has  implemented  a  new  remuneration 
policy for its senior management with the following elements: 

(cid:120)  A one-off substantial performance based option grant to key senior management at market value  
(cid:120)  No further grants intended to said senior management through the end of the three-year measurement period 
(cid:120)  Cliff vesting on December 31, 2016 at different levels dependent on achievement against the performance 

target (zero below 50% up to 100% vesting at 90% attainment) 

(cid:120)  10 year option term 

Page 31 

 
 
 
 
  
  
  
  
   
   
   
   
   
   
     
  
    
  
  
  
  
 
  
 
 
 
 
Performance measure - The performance measure is the driving factor behind the new policy.  Broadly, the 
target is EBITDA equal to 90% of the term debt and lease principal payments, and all interest payments, which 
are  due  during  the  performance  period.  Such  payments  would,  on  the  basis  of  current  obligations,  amount  to 
approximately $3.0 million in  total.   Achievement of this objective  will result in full vesting. The committee 
and board believe that achievement of the objective will result in the creation of significant stockholder value. 

Under  the  Company’s  2014  Stock  Incentive  Plan  (the  2014  Plan),  the  Company  may  issue  options, 
restricted  stock,  restricted  stock  units  and  other  stock-based  awards  to  its  employees,  officers,  directors, 
consultants  and  advisors.  An  aggregate  of  10,200,000  shares  of  the  Company’s  common  stock  were  initially 
reserved  for  issuance  under  the  2014  Plan.  In  addition,  there  is  an  annual  increase  to  the  number  of  shares 
reserved for issuance under the 2014 Plan equal to the lesser of (i) 2,000,000 shares of common stock, (ii) 5% 
of  the  outstanding  shares  of  common  stock  of  the  Company,  or  (iii) an  amount  determined  by  the  Board  of 
Directors of the Company.   

        As of December 31, 2014, there were 2,000,000 shares available to be issued from this plan. 

In May, 2014, the Board of Directors approved the Seventh Amended and Restated Policy Regarding 
Compensation  of  Independent  Directors,  (i)  cash  compensation  is  $25,000  per  annum  paid  in  arrears  each 
quarter in installments of $6,250; and (ii) options to purchase 150,000 shares of the Company’s common stock, 
$.001  par  value  per  share  (the  “Common  Stock”),  such  that  each  Independent  Director  who  is  serving  as 
director of the Company on the date of each annual meeting of stockholders (or special meeting in lieu thereof) 
beginning  with  the  2014  annual  meeting,  shall  automatically  be  granted  on  such  day  an  option  (the  “Option 
Award”) entitling the recipient to acquire 150,000 shares of Common Stock, pursuant to  the Company’s 2007 
Stock Incentive Plan (the “Plan”).  

In May 2007, the Company adopted the 2007 Stock Option and Incentive Plan (the 2007 Option Plan) for 
the purpose of issuing both Incentive Options and Nonqualified Options to officers, employees and directors of 
the company. No further grants are allowed under this plan. 

In May 2004, the Company adopted the 2004 Stock Option and Incentive Plan (the 2004 Option Plan) for 
the purpose of issuing both Incentive Options and Nonqualified Options to officers, employees and directors of 
the company. No further grants are allowed under this plan. 

In May 2000, the Company adopted the 2000 Stock Option and Incentive Plan for the purpose of issuing 
both  Incentive  Options  and  Nonqualified  Options  to  officers,  employees  and  directors  of  the  Company.  No 
further grants are allowed under this plan. 

The following table summarizes information about the stock options outstanding as of December 31, 2014.   
The intrinsic value on the options outstanding, and exercisable, at December 31, 2014 is approximately $8,000.  
There is no intrinsic value on the options outstanding, and exercisable, at December 31, 2013. 

Page 32 

 
 
 
 
 
 
 
 
 
During 2014 and 2013, the Remuneration Committee approved various qualified and non-qualified stock option 
awards to purchase shares of the Company’s common stock to various officers, directors and employees.  There 
were 10,500,000 options granted during the year ended December 31, 2014 and 3,500,000 options were granted 
during  the  year  ended  December  31,  2013.    These  options  vest  over  a  one  year,  two  year  or  a  four  year 
anniversary of the grant date, provided that the recipient continues to serve the Company in that capacity until 
each  such  vesting.    The  weighted  average  assumptions  for  grants  during  the  years  ended  December 31,  2014 
and December 31, 2013 used in the Black-Scholes option pricing model were as follows:  

Twelve months Ended 
 December 31,  
2014 

Twelve months Ended 
December 31,  
2013 

Volatility……………………………………….. 
Expected option life…………………………… 
Interest rate (risk free)…………………………. 
Dividends………………………………………. 
Weighted average grant date fair value………... 

237.58% 
5.1 years 
1.71% 
$0 
$0.0366 

224.1% 
4.5 years 
1.19% 
$0 
$0.02 

Balance at December 31, 2012 .........................
Granted .....................................................
Exercised ..................................................
Cancelled ..................................................

Balance at December 31, 2013 .........................

Weighted 
Average 
Remaining 
Contractual 
Term 
(in Years)  
6.70 

Weighted 
Average 
Exercise Price 
per Share ($) 
0.19  
            0.02   
                 - 
            0.92 

0.13  

7.63 

Options 
Outstanding  
9,355,890 
3,500,000 
- 
(  240,200) 

12,615,690 

Vested and Exercisable at December 31, 2013 

           5,519,840 

            0.20 

          6.24 

Balance at December 31, 2013 .........................
Granted .....................................................
Exercised ..................................................
Cancelled ..................................................

Balance at December 31, 2014 .........................

Vested and Exercisable at December 31, 2014 

12,615,690 
10,500,000 
- 
(  750,650) 

22,365,040 

 8,175,238 

0.13  
            0.04   
                 - 
            0.56 

0.07  

0.11 

7.63 

7.97 

6.32  

Vested and Expected to Vest at December 
31, 2014 ..................................................

                     21,827,405 

                    0.07 

                   7.91 

Page 33 

 
  
 
 
 
  
  
  
  
  
 
 
 
 
  
 
  
 
  
 
  
 
  
  
 
 
 
  
 
  
  
 
 
  
  
  
  
 
 
 
 
  
 
  
 
  
 
  
 
  
  
 
 
 
  
 
  
  
 
 
 
  
  
  
  
  
  
  
  
Range of 
Exercise Prices 
$    0.02 –    0.99 

Options 
Outstanding  
22,365,040  

Weighted 
Average 
Contractual 
Life (years)  
8.0  

Weighted 
Average 
Exercise 
Price  

Options 
Exercisable  

Weighted 
Average 
Exercise 
Price  

$ 

0.07  

8,175,238   $ 

0.11  

At December 31, 2014, there was approximately  $419,000 of total unrecognized compensation cost related to 
stock  options  granted.  The  cost  is  expected  to  be  recognized  over  the  next  1.38  years.  Total  stock  option 
expense recorded in 2014 and 2013 was approximately $280,000 and $169,000, respectively.   There were no 
options exercised during 2014 and 2013. 

(12) EMPLOYEE STOCK PURCHASE PLAN  

In May 2000, the Company adopted the 2000 Employee Stock Purchase Plan (the Stock Purchase Plan), 
which permits the eligible employees of the Company and its subsidiaries to purchase shares of the Company’s 
common stock, at  a discount, through regular monthly payroll deductions of up to 10% of their pre-tax gross 
salary. Subject to adjustment for stock splits, stock dividends and similar events, a maximum of 300,000 shares 
of common stock may be issued under the Stock Purchase Plan. During the years ended December 31, 2014 and 
2013, there were no shares issued under the Stock Purchase Plan.  

(13) EMPLOYEE DEFINED CONTRIBUTION PLANS  

On  January 17,  1994,  the  Company  established  the  ProPhotonix  Limited  (formerly  StockerYale,  Inc.) 
401(k)  Plan  (the  Plan).  Under  the  Plan,  employees  are  allowed  to  make  pre-tax  retirement  contributions.  In 
addition, the Company may make matching contributions, not to exceed 100% of the employee contributions, 
and profit sharing contributions at its discretion. The Company made matching contributions of $27,000 in the 
year ended December 31, 2014 and $33,000 in the year ended December 31, 2013. The Company incurred costs 
of approximately $1,200 in 2014 and approximately $1,100 in 2013 to administer the Plan. 

The Company also has voluntary contribution pension schemes in Ireland and in the United Kingdom.  In 
the United Kingdom, the Company contributes a maximum of 3% of the participating employee salaries, with 
one exception, where the maximum contribution is 10%.  The plan is voluntary, with plan administration costs 
coming out of the plan itself.  The Company made contributions of approximately $46,000 and $44,000 in the 
years ended December 31, 2014 and 2013, respectively.  In Ireland, the Company also has a voluntary plan that 
matches contributions for those participating employees with minimum of 6 months of service.  After two years 
of service, the Company will match up to a maximum of 5% of salary.   The Company made contributions of 
approximately  $32,000  and  $20,000  in  the  years  ended  December  31,  2014  and  2013,  respectively.    Plan 
administration costs come out of the plan itself. 

Other obligations and contingent liabilities 

(14) COMMITMENTS AND CONTINGENCIES  

 The  Company  leases  approximately  3,600  square  feet  for  its  corporate  headquarters  and  sales  office  in 
Salem,  New  Hampshire.    The  term  of  the  lease  requires  monthly  tenant  at-will  payments  with  a  90  day 
termination notice.  Base rent is $2,550 per month plus the tenant’s share of expenses.  

Page 34 

 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
 
 
 
 
 
 
ProPhotonix (IRL) Limited leases approximately 10,000 square feet for its operations in Cork, Ireland. The 
original five year lease term ended on August 22, 2013 with rent and service charges of €102,000 per year.  The 
lease is still under re-negotiation, however, the rent and service charges are now €72,000 per year. 

ProPhotonix  Limited,  a  U.K.  subsidiary,  leases  approximately  13,000  square  feet  of  space  in  Hatfield 
Broad  Oak,  Hertfordshire,  U.K.  The  original  lease  had  a  term  of  nine  years  ending  September  29,  2013  at 
£87,000 per year, at which time the Company renegotiated the lease for an additional 3 years.  Rent charges are 
£70,000 per year under the renegotiated terms of the lease. 

The  Company  utilizes,  or  has  assumed,  capital  leases  to  finance  purchases  of  equipment  or  vehicles.  At 
December  31,  2014,  these  capital  leases  were  paid  in  full.    There  was  approximately  $10,000  payable  in 
principal and interest under these leases at December 31, 2013. The Company records depreciation expense on 
assets acquired under a capital lease in the consolidated statement of operations. 

The net book value of assets acquired under capital leases at December 31, 2014 and December 31, 2013, 

is as follows:   

2014 
Assets under capital lease ............................................... $      594,000 
Less—accumulated depreciation ....................................

       (582,000)  

2013  
$      631,000   
       (606,000)  

Assets under capital lease, net ........................................ $        12,000 

  $        25,000 

Scheduled future maturities of debt, and operating lease obligations for the next five years:  

Due by period 

2015  

2016  

2017  

2019  

2018  
in thousands 

Total  

Debt obligations ..................... $  770   $ 1,066   $  576   $ 
Operating lease obligations ....

        - 

116  

82  

-    

   - 

$  886  $ 1,148   $  576   $ 

-    

- 
$ 
        - 

$ 

- 

$2,412  
     198  

$2,610  

The Company expensed approximately $241,000 and $269,000 in rent for the years ended December 31, 2014 
and 2013, respectively. 

(15) LEGAL PROCEEDINGS 

 The  Company  is  party  to  various  legal  proceedings  generally  incidental  to  its  business.  Although  the 
disposition of any legal proceedings cannot be determined with certainty, it is the Company’s opinion that any 
pending or threatened litigation will not have a material adverse effect on the Company’s results of operations, 
cash flow or financial condition.  

Page 35 

 
 
 
 
 
 
  
  
  
 
  
  
  
 
 
 
  
  
  
 
  
  
  
  
  
  
 
 
 
   
 
 
   
  
  
  
  
  
 
  
  
  
  
  
  
  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
  
  
(16) SEGMENT INFORMATION  

Operating segments are identified as components of an enterprise about which separate discrete financial 
information is available for evaluation by the chief decision-making group, in making decisions how to allocate 
resources  and  assess  performance.  The  Company’s  chief  decision-maker  is  the  Chief  Executive  Officer.  The 
Company’s accounting policies and method of presentation for segments is consistent with that used throughout 
the consolidated financial statements. 

The Company operates in two segments: LED’s (light emitting diode systems) and Laser & Diodes.  In 
the  LED  segment,  the  Company  designs  and  manufactures  LED  systems  for  the  inspection,  machine  vision, 
medical  and  military  markets.  The  Laser  &  Diodes  segment  distributes  laser  diodes  and  designs  and 
manufactures  custom  laser  diodes  modules  for  industrial,  commercial,  defense  and  medical  applications.  The 
policies relating to segments are the same as the Company’s corporate policies. 

The  Company  evaluates  performance  and  allocates  resources  based  on  revenues  and  operating  income 
(loss). The operating profit / (loss) for each segment includes selling, research and development and expenses 
directly attributable to the segment.  In addition, the operating  profit / (loss) includes amortization of acquired 
intangible assets, including any impairment of these assets and of goodwill. Certain of the Company’s indirect 
overhead  costs,  which  include  corporate  general  and  administrative  expenses,  are  allocated  between  the 
segments  based  upon  an  estimate  of  costs  associated  with  each  segment.  Segment  assets  include  accounts 
receivable,  inventory,  machinery  and  equipment,  goodwill  and  intangible  assets  directly  associated  with  the 
product line segment.  

2014  

2013  

(In thousands) 

Years Ended December 31 
Revenues: 

LEDs ...........................................................................................................  
Laser & diodes ............................................................................................  

$        7,111  
          9,320 

$        6,599  
          9,000 

Total revenues .............................................................................................  

$ 

16,431  

$ 

15,599  

Gross profit: 

LEDs ...........................................................................................................  
Laser & diodes ............................................................................................  

$        3,288  
3,137  

$        2,947  
3,024  

Total gross profit .........................................................................................  

$ 

6,425  

$ 

5,971  

Operating profit (loss) 

LEDs ...........................................................................................................  
Laser & diodes ............................................................................................  

$          126  
(30)  

$        (806)  
(375)  

Total operating profit / (loss) .......................................................................  

$ 

96  

$ 

(1,181)  

Page 36 

 
 
 
 
  
  
   
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
 
  
 
 
 
 
Years Ended December 31 
Current assets: 

LEDs ...........................................................................................................  
Laser & diodes ............................................................................................  
Corporate .....................................................................................................  

Total current assets ......................................................................................  

Property, plant & equipment: 

LEDs ...........................................................................................................  
Laser & diodes ............................................................................................  
Corporate .....................................................................................................  

Total property, plant & equipment ..............................................................  

Intangible assets: 

LEDs ...........................................................................................................  
Laser & diodes ............................................................................................  
Corporate .....................................................................................................  

Total intangible assets .................................................................................  

Goodwill: 

LEDs ...........................................................................................................  
Laser & diodes ............................................................................................  

Corporate .....................................................................................................  

Total goodwill .............................................................................................  

Other assets: 

LEDs ...........................................................................................................  
Laser & diodes ............................................................................................  
Corporate .....................................................................................................  

Total other assets .........................................................................................  

Years Ended December 31 
Total assets: 

LEDs ...........................................................................................................  
Laser & diodes ............................................................................................  
Corporate .....................................................................................................  

Total assets ..................................................................................................  

Revenues by geographic area: 

United States ...............................................................................................  
Canada, Mexico & So. America ..................................................................  
Europe .........................................................................................................  
Asia & the rest of the world ........................................................................  

2014  

2013  

(In thousands) 

2,201  
2,222  
380  

4,803  

64  
116  
4  

184  

—   
— 
—    

—  

429  

—    
—    

429  

30   
—    
176  

206  

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

1,984  
2,737  
463  

5,184  

179  
120  
4  

303  

—   
102  
—    

102  

486  
—   

—    

486  

28   
—    
326  

354  

2014  

2013  

(In thousands) 

2,797  
2,265  
560  

5,622  

4,724  
419  
8,531  
2,757  

$ 

$ 

2,677  
2,959  
793  

6,429  

4,585  
274  
8,148  
2,592  

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

Total ......................................................................................................................  

$ 

16,431  

$ 

15,599  

Page 37 

 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
 
 
 
 
  
  
  
  
  
  
  
  
 
 
 
 
  
  
  
  
  
  
  
  
 
 
 
 
  
  
  
  
  
  
  
  
 
 
 
 
 
 
  
  
  
  
  
  
  
  
 
 
 
 
  
  
  
  
  
  
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
 
 
 
 
 
 
  
  
  
  
  
  
  
  
 
 
 
 
 
 
  
  
  
  
  
  
The Company’s long-lived assets consist of property, plant and equipment, goodwill and intangible assets located in the 

following geographic locations:  

Years Ended December 31 
Long-lived assets by geographic area: 

United States and North America ................................................................  
Europe ..........................................................................................................  
UK ...............................................................................................................  

Total ......................................................................................................................  

$ 

$ 

4  
546  
64  

614  

$ 

$ 

4  
666  
222  

892  

2014  

2013  

(In thousands) 

(17) SUBSEQUENT EVENTS 

The Company has evaluated subsequent events through March 24, 2015, the date which the financial statements 
were  available  to  be  issued,  and  there  were  no  additional  events  that  impacted  these  financial  statements  or 
required additional disclosure to the financial statements.  

Page 38 

 
  
  
 
 
 
  
  
  
  
  
  
  
  
 
 
 
 
  
  
  
  
  
  
  
 
 
  
 
(This page left intentionally blank.) 

Page 39 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BR743465-0315-AR